SCHEMBL8083331

SCHEMBL8083331

CNC(=O)SS

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28489036 0.97
SCHEMBL14227417 0.72 LMNA (0.35)
SCHEMBL10919262 0.69
SCHEMBL3434601 0.69
SCHEMBL18972158 0.67
SCHEMBL27377368 0.67
SCHEMBL1482550 0.67
SCHEMBL31440713 0.67 LMNA (0.32)
SCHEMBL15338442 0.67
SCHEMBL8074359 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104098587-A 2, 4-diamino-thieno [2, 3-d] pyrimidine derivative as well as preparation method and application thereof UNIV CAPITAL NORMAL 2014-10-15 CN claimed
CN-101759654-B 4-quinazolinone-6-methylamino dithiocarbamate as well as medical composition and application thereof CAPITAL NORMAL UNIV. (CN) 2011-12-28 CN claimed
CN-101759654-A 4-quinazolinone-6-methylamino dithiocarbamate as well as medical composition and application thereof UNIV CAPITAL NORMAL 2010-06-30 CN claimed
CN-116313255-A Corrosion-resistant cable for data transmission and preparation method thereof 盐城联翔电子科技有限公司 2023-06-23 CN disclosed
CN-104098587-A 2, 4-diamino-thieno [2, 3-d] pyrimidine derivative as well as preparation method and application thereof UNIV CAPITAL NORMAL 2014-10-15 CN disclosed
CN-101759654-B 4-quinazolinone-6-methylamino dithiocarbamate as well as medical composition and application thereof CAPITAL NORMAL UNIV. (CN) 2011-12-28 CN disclosed
CN-101759654-A 4-quinazolinone-6-methylamino dithiocarbamate as well as medical composition and application thereof UNIV CAPITAL NORMAL 2010-06-30 CN disclosed
WO-2009017838-A2 COMBINATIONS OF JAK-2 INHIBITORS AND OTHER AGENTS EXELIXIS, INC. (US) 2009-02-05 WO disclosed
CN-100434425-C 4-quinazolone derivative and its use in anti-tumor medicine UNIV CAPITAL NORMAL (CN) 2008-11-19 CN disclosed
CN-1683344-A 4-quinazolone derivative and its use in anti-tumor medicine UNIV CAPITAL NORMAL (CN) 2005-10-19 CN disclosed